These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8444677

  • 1. RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.
    Pfaller MA, Barry AL, Fuchs PC.
    J Antimicrob Chemother; 1993 Jan; 31(1):81-8. PubMed ID: 8444677
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
    Jones RN, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.
    Fuchs PC, Jones RN, Barry AL, Ayers LW, Gavan TL, Gerlach EH, Thornsberry C.
    Diagn Microbiol Infect Dis; 1987 May; 7(1):29-35. PubMed ID: 3121241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
    Qadri SM, Ueno Y, Ayub A.
    Chemotherapy; 1993 May; 39(6):386-9. PubMed ID: 8222864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.
    Jones RN.
    Diagn Microbiol Infect Dis; 1990 May; 13(3):253-9. PubMed ID: 2116952
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
    Beskid G, Siebelist J, McGarry CM, Cleeland R, Chan K, Keith DD.
    Chemotherapy; 1990 May; 36(2):109-16. PubMed ID: 2107064
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.
    Pfaller MA, Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):893-5. PubMed ID: 8494387
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
    Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC.
    J Antimicrob Chemother; 1993 Feb; 31(2):273-80. PubMed ID: 8463172
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.
    Edelstein PH, Edelstein MA.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2559-61. PubMed ID: 1489206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.